1. Home
  2. ITRG vs THW Comparison

ITRG vs THW Comparison

Compare ITRG & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

HOLD

Current Price

$2.71

Market Cap

543.8M

ML Signal

HOLD

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

HOLD

Current Price

$12.63

Market Cap

513.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRG
THW
Founded
1997
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Finance Companies
Sector
Basic Materials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
543.8M
513.9M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
ITRG
THW
Price
$2.71
$12.63
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$5.13
N/A
AVG Volume (30 Days)
2.5M
87.0K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$67.34
N/A
Revenue Next Year
$25.89
N/A
P/E Ratio
$45.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$10.10
52 Week High
$4.87
$13.19

Technical Indicators

Market Signals
Indicator
ITRG
THW
Relative Strength Index (RSI) 37.94 56.16
Support Level $2.57 $12.33
Resistance Level $3.29 $12.78
Average True Range (ATR) 0.13 0.23
MACD -0.02 0.02
Stochastic Oscillator 13.71 72.36

Price Performance

Historical Comparison
ITRG
THW

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

Share on Social Networks: